by Eric Christianson | Sep 1, 2024 | Gastrointestinal Case Studies
A 76-year-old male has a past medical history of hypertension, diarrhea, mild cognitive impairment, diabetes, osteoarthritis, and gout. He has had a concern that has been ongoing for about 3 months with the symptoms recently escalating over the last 1-2 weeks....
by Eric Christianson | Jul 3, 2024 | Gastrointestinal Case Studies
JE is a 77-year-old male. He reports significant constipation despite the use of three laxative medications. In this case summary, I will outline the most important medications that can contribute to constipation polypharmacy. Past medical history includes:...
by Eric Christianson | Aug 31, 2022 | Gastrointestinal Case Studies
Lactulose (Enulose, Generlac) is technically a laxative medication. While it can be used for that purpose, it is fairly rare in clinical practice that you see it used for that indication. Lactulose, in my experience, is used more frequently for patients who have...
by Eric Christianson | Jan 13, 2021 | Educational Case Studies For Pharmacists, Gastrointestinal Case Studies, Polypharmacy Cases And The Prescribing Cascade
Somedays I scratch my head more than others…today was one of those days. Seeing Senna and loperamide scheduled together made me scratch it REAL hard. A 77-year-old male was complaining of constipation and Miralax PRN was added to help. As I started reviewing the...
by Eric Christianson | Jun 13, 2018 | Educational Case Studies For Pharmacists, Gastrointestinal Case Studies
In this case scenario, I’m going to demonstrate and unusual side effect of galactorrhea. Reglan induced galactorrhea is a possibility due to the mechanism of dopamine blockade. The case: A 46 year old female obese female has a history of type 2 diabetes. She...
by Eric Christianson | Jun 7, 2017 | Educational Case Studies For Pharmacists, Endocrine Case Studies, Gastrointestinal Case Studies
Diabetes is a disease that millions are affected by. It can be very challenging trying to figure out which medication or medication combination is best for a patient. While extremely rare, the GLP-1’s and DPP4 inhibitors have been potentially associated with...
